Browsing by Author "Sharma, S. P."

Now showing 1 - 5 of 5
  • Thumbnail Image
    Item
    Clinicopathological study of benign and malignant ovarian tumours and the role of HER2/neu and ER expression in these tumours
    (Medip Academy, 2019-06) Verma, Nidhi; Grover, Kriti; Sharma, S. P.; Gupta, Priya; Singh, Preeti; Singh, Anshu
    Background: Ovarian cancers represent the 6th most common cancer among females and are the most common cause of death from gynaecological cancers in the world. The aim is to do clinicopathologic study of ovarian tumours along with evaluation of the expression of estrogen receptor (ER) and human epidermal growth factor receptor (HER2/neu).Methods: A total of 85 cases of ovarian tumors were studied and immunohistochemistry was performed with specific antibodies against ER and HER2/neu as per standard protocol.Results: In present study, surface epithelial tumours were the commonest type comprising 64 cases (75.2%), followed by Germ cell tumours, 17cases (20%) and sex cord stromal tumours, 04 cases (4.8%).Among the surface epithelial tumours , ER‑positive cases were higher in malignant (71.4%) tumours as compared to borderline tumours (33.3%) and benign tumours (7.7%) while Her2/neu positive cases were higher in borderline (66.7%) tumours as compared to malignant tumours (42.9%) and benign tumours (15.3%).Among the germ cell tumours, ER expression was positive in 62.5% cases of mature teratoma while HER2/neu expression was positive in only 12.5% cases of mature teratoma. None of the sex cord stromal tumours showed positive expression of ER and HER2/neu.Conclusions: Positive expression of estrogen receptors is seen predominantly in surface epithelial malignancies and in mature teratoma. It proves the mitogenic role of estrogen in ovarian tumours. Her-2 neu was expressed mainly in malignant tumours. This suggests their carcinogenic role. This also helps in differentiating borderline and malignant tumours.
  • Thumbnail Image
    Item
    In Vitro Evaluation of Carbachol and Endothelin on Contractility of Colonic Smooth Muscle in Hirschsprung’s Disease.
    (2016-01) Tripathi, Brijesh K.; Gangopadhyay1, A. N.; Sharma, S. P.; Kar, Amrita G.; Mandal, Maloy B.
    Background: The hypomotility of colon observed in Hirschsprung’s disease (HD) has been attributed to congenital aganglionosis only. So far, it is not clear whether the contractility of colonic smooth muscle in this condition is altered or not. Therefore, the present study attempted to understand the contractile status of colonic segments of HD patients by examining carbachol and endothelin (ET-1) evoked colonic smooth muscle contractions in vitro. Methods: Contractile responses were recorded from strips of colonic segments obtained from HD patients, using organ bath preparations. Cholinergic agonist carbachol and ET-1 along with their antagonists were used to evoke contractile responses. Thereafter, the samples were histopathologically confirmed for HD. Results: Colonic strips of HD did not show any spontaneous contractions but responded to carbachol and ET-1 to a lesser extent. In HD, response of carbachol was blocked by atropine and hexamethonium by nearly 73% and 50% respectively. ET-1 induced contractile responses were blocked by ET-A and ET-B antagonist up to 40%, signifying the possible role of ET-A and ET-B receptors in HD colon contractility. Conclusion: As evidenced by lack of spontaneous contractions and impaired carbachol and ET-1-induced contractile responses, it is concluded that, in addition to aganglionosis, decreased contractility of colonic smooth muscle may contribute to hypomotility observed in patients with HD.
  • No Thumbnail Available
    Item
    Medicinal plants used during pregnancy, childbirth and postpartum care in India: a systematic review
    (Medip Academy, 2023-10) Sharma, P. P.; Sharma, S. P.
    Use of plant medicine during pregnancy, childbirth and in postpartum care has grown significantly worldwide and is remarkably well-known in different regions of India. Traditional plant medicine has the potential for treating various diseases/ailments and is evidenced by well-known pharmacopeia of India - Ayurveda. This paper reviews the research papers on plant medicine utilization during pregnancy, childbirth and for postpartum care based on information published from India. Total 206 uses of 146 medicinal plants belong to 69 families, of which 125 are herbs, 39 trees, 26 shrubs and 16 climbers. Plant parts used as medicine for treating various disorders during pregnancy, childbirth and postpartum are 75 leaves, 48 roots, 23 seeds, 19 whole plants, 15 fruits, 11 barks, stem and flower 5 each, gum 2, latex 1, while in 24 cases part used is not specified. The use of plants for treating various disorder/ailments during pregnancy, of these most prevalent use is as a tonic (23 uses) which followed by vomiting (10), abdominal pain (9), to facilitate delivery (6) and so on. Use of plants during childbirth, maximum number of plants used to facilitate deliver (32 uses), for labor pain (15), and to induce labor (12). While use of plants for postpartum care, includes (37 uses) for lactation, (10) for haemorrhage, and 7 for abdominal pain.
  • No Thumbnail Available
    Item
    Medicinal plants used for treating infertility and related disorders of women in India: a systematic review
    (Medip Academy, 2023-12) Sharma, P. P.; Sharma, S. P.
    Assessment of plant medicine for treating infertility and related disorders is making headway universally recent couple of decades to bring out new effective and safe substances as an alternative medicine. Present paper reviews the published literature on plant medicine used for female infertility and related disorders. The 53 research papers or reports shortlisted are based studies under taken in India. Total 459 uses of 202 medicinal plants classified under 84 families. Total 62 trees, 55 shrubs, 79 herbs and 3 climbers are reported. Most used plant parts for making medicine are roots in 111 formulations and leaf in 101 formulations. Medicinal plants used for infertility are 84, while for related disorder like leucorrhoea 79 plants, menorrhagia 53, dysmenorrhea 29, amenorrhea 23 and 22 plants used to regulate menstruation. Additional investigations could be helpful to verify the claims reported using a specific formulations or recipes and which will subsequently result in providing possible the alternative medicine for the treatment of female infertility.
  • No Thumbnail Available
    Item
    Patterns and causes of maternal mortality in tertiary care hospital in Maharashtra, India: a 10-year retrospective study
    (Medip Academy, 2023-08) Wakode, S. R.; Sharma, S. P.; Patil, A. S.; Kiran, P. M.
    Background: Maternal death is a catastrophe, as death of a mother can the entire family. The aim of present study is to find out major patterns, reasons and complications leading to maternal deaths. Methods: A retrospective study was conducted for last 10 years from January 2013 to December 2022 by studying the records of a tertiary care hospital to study the maternal mortalities and complications leading to death. Maternal deaths were analyzed by considering different facets, such as age at death, gravida, locality of residence, admission death interval and direct and indirect cause/s of death, etc. Results: During the study period, total of 107753 live births and 202 maternal deaths have been recorded. The average maternal mortality rate of last ten years was 187.46/100000 live births. Age wise maternal mortality during the study period was high in the age 19 to 25. Major direct cause of maternal mortality was postpartum hemorrhage, (23%) and major indirect cause observed was anemia (43%). Admission to death interval time indicates that delay in provision of treatment and referral to tertiary care hospital might be the reason responsible for high maternal deaths. Conclusions: Maternal deaths can be prevented by improving the health care facilities, ensuring skilled attendants and required basic medication. This is high time to mobilize universal, national, regional, and community-based commitment to decrease maternal mortalities.